Research Impact

h-index

N/A

Research impact score

Publications

0

Total publications

Trial Results

0

Published trial results

Citations

0

Total citations

Drug Portfolio

Analytics

Trial Phases

Phase 31

Trial Status

Completed1
Other1

Role Distribution

Principal Investigator1
Other Roles1
PI Rate50%

Activity Timeline

Clinical Trials (2)

NCT06758947Phase 3Completed
Use of Selective JAK Inhibitor in ILD and Skin Tightness of Systemic Sclerosis Versus MMF
Interstitial Lung Disease Due to Systemic Disease (Disorder)
PrincipalinvestigatorStart date: 2023-01-15
Plexin D1 as a Potential Biomarker inPM/DM
DermatomyositisPolymyositis
Studydirector

Research Network

Collaboration Network

4 collaborators·6 connections
Network Legend
KOL
Current Investigator
CO
High-influence Collaborator
CO
Collaborator
Click: view details
Double-click: go to profile
Drag: move node

Research Areas & Affiliations

Similar Key Opinion Leaders

Discover other key opinion leaders with similar research profiles, therapeutic areas, and collaboration networks.

10 similar investigators found

Helal F. Hetta, professor

Assiut University

Related
1 trials

Shared therapeutic areas:

DermatomyositisPolymyositis

Worked with same sponsors:

Assiut University
Collaborated on 1 trial
Similarity Score24%

Ahmed Abdel Khalek Hafez, lecturer

Assiut University

Related
1 trials

Shared therapeutic areas:

DermatomyositisPolymyositis

Worked with same sponsors:

Assiut University
Collaborated on 1 trial
Similarity Score24%

Eman Ahmed Hamed Omran, professor

Assiut University

Related
1 trials

Shared therapeutic areas:

DermatomyositisPolymyositis

Worked with same sponsors:

Assiut University
Collaborated on 1 trial
Similarity Score24%

Maria Antonietta D'Agostino

Fondazione Policlinico Universitario Agostino Gemelli IRCCS

Related
3 trials

Shared therapeutic areas:

DermatomyositisPolymyositis
Similarity Score20%

Adam I Schiffenbauer, M.D.

National Institute of Environmental Health Sciences (NIEHS)

Related
4 trials

Shared therapeutic areas:

DermatomyositisPolymyositis
Similarity Score20%

Ingrid E Lundberg, MD, PhD

Karolinska Institutet

Related
2 trials

Shared therapeutic areas:

DermatomyositisPolymyositis
Similarity Score20%

Petros Efthimiou, MD

New York Presbyterian Brooklyn Methodist Hospital

Related
1 trials

Shared therapeutic areas:

DermatomyositisPolymyositis
Similarity Score20%

Chester V. Oddis, MD

University of Pittsburgh

Related
2 trials

Shared therapeutic areas:

DermatomyositisPolymyositis
Similarity Score20%

Andrew L Mammen, M.D.

National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)

Related
2 trials

Shared therapeutic areas:

DermatomyositisPolymyositis
Similarity Score20%

Helene Alexanderson, PhD, RPT

Karolinska University Hospital / Karolinska Institutet

Related
2 trials

Shared therapeutic areas:

DermatomyositisPolymyositis
Similarity Score20%

Publications (0)

No publications found for this investigator.

Clinical Trials (2)

Showing 2 of 2 trials

NCT06758947Phase 3PrincipalInvestigator

Use of Selective JAK Inhibitor in ILD and Skin Tightness of Systemic Sclerosis Versus MMF

Interstitial Lung Disease Due to Systemic Disease (Disorder)
Completed
NCT05637931StudyDirector

Plexin D1 as a Potential Biomarker inPM/DM

DermatomyositisPolymyositis
Unknown

All 2 trials loaded